Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2010 | 03-2009 | 03-2008 | 03-2007 | 03-2006 | |
| Sales | 10,518,920 | 0 | 9,395,181 | 7,650,385 | 7,993,391 |
| Gross Profit | 10,518,920 | N/A | 9,395,181 | 7,650,385 | 7,993,391 |
| Operating Income | 10,518,920 | N/A | 9,395,181 | 7,650,385 | 7,993,391 |
| Pre-tax Income | 10,518,920 | 0 | 9,395,181 | 7,650,385 | 7,993,391 |
| Net Income Continuous | 1,319,153 | 1,761,156 | 1,714,041 | 1,090,978 | 942,251 |
| Net Income | $1,319,153 | $1,761,156 | $1,714,041 | $1,090,978 | $942,251 |
| EPS Basic Total Ops | 0.57 | 0.74 | 0.67 | 0.41 | 0.34 |
| EPS Basic Continuous Ops | 0.55 | 0.70 | 0.66 | 0.41 | 0.33 |
| EPS Diluted Total Ops | 0.57 | 0.74 | 0.67 | 0.41 | 0.34 |
| EPS Diluted Continuous Ops | 0.55 | 0.70 | 0.66 | 0.41 | 0.33 |
| EBITDA(a) | $10,518,920 | $N/A | $9,395,181 | $7,650,385 | $7,993,391 |